Esperion Therapeutics, Inc. (ESPR) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 207.87M | +11.0% |
| 2024 | 187.18M | +81.5% |
| 2023 | 103.11M | +55.3% |
| 2022 | 66.41M | +129.8% |
| 2021 | 28.90M | +5.2% |
| 2020 | 27.47M | +1.4% |
| 2019 | 27.09M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 207.87M | +11.0% |
| 2024 | 187.18M | +81.5% |
| 2023 | 103.11M | +55.3% |
| 2022 | 66.41M | +129.8% |
| 2021 | 28.90M | +5.2% |
| 2020 | 27.47M | +1.4% |
| 2019 | 27.09M | — |